Investor FAQs

Show all

Aquinox’s corporate headquarters are located at 450 – 887 Great Northern Way, Vancouver, British Columbia, V5T 4T5, Canada. The main office telephone number is (604) 629-9223.
The Aquinox ticker is AQXP and it is traded on the NASDAQ Global Market.
Aquinox’s IPO was on March 7th, 2014
The underwriters for the IPO were Jeffries LLC, Cowen and Company, and Canaccord Genuity.
You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.
You can view our management team by visiting the Management section of our Investor Relations website.
Aquinox’s fiscal year ends on December 31st
Deloitte LLP
Aquinox does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business. 
Aquinox does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.
You can contact Aquinox’s Investor Relations via email at: ir@aqxpharma.com In addition, you can reach Investor Relations by calling (604) 629-9223.